spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  NeuroMed 

 HSMN NewsFeed - 30 Oct 2020
Sana Biotechnology Announces Acquisition of Oscine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Aug 2019
InMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Sep 2013
Osmotica Pharmaceutical Corp. Announces the Appointment of Gene Wright, Pharm.D., Ph.D. as Vice President, Head of Global Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2013
BG Medicine Appoints Dr. Paul Sohmer as Chief Executive Officer
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 23 Apr 2012
ETView Medical, Ltd. and Champ Medics Co., Ltd. (Champ Medics) Execute Distribution Agreement
Devices Distribution
 HSMN NewsFeed - 9 Apr 2012
ETView Medical, Ltd. and Medutech S.A. DE C.V. (Medutech) Execute Distribution Agreement
Devices Distribution
 HSMN NewsFeed - 7 Feb 2012
ETView Medical, Ltd., and NeuroMed Ltd. (NeuroMed), Execute Distribution Agreement
Devices Distribution
 HSMN NewsFeed - 15 Feb 2011
Nfocus Neuromedical, Inc. Luna Aneurysm Embolization System Receives CE Mark
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 12 Apr 2010
FORMA Therapeutics Appoints Robert Forrester Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2010
FDA Approves EXALGO (Hydromorphone HCL) Extended-Release Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jan 2010
Noven Announces New Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2009
Stockholders of CombinatoRx and Neuromed Vote for Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Nov 2009
FDA Extends Review of NDA for Exalgo
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Aug 2009
Nfocus Neuromedical Obtains CE Approval for New Vascular Reconstruction Device
Devices Interventional Regulatory
 HSMN NewsFeed - 29 Jul 2009
Nfocus Neuromedical Announces European Approval for Novel Guiding Catheter at Society of NeuroInterventional Surgery
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 2 Jul 2009
CombinatoRx and Neuromed Sign Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 17 Jun 2009
Neuromed Announces Sale of U.S. Rights to Drug Candidate Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) to Mallinckrodt
Biopharmaceuticals
 HSMN NewsFeed - 8 Apr 2009
ORTHOCON Announces Appointment of New CEO and $25 Million Series B Financing
Devices Venture Capital Personnel
 HSMN NewsFeed - 23 Mar 2009
Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 29 Apr 2008
Neuromed Names Sean Cunliffe Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2008
Nfocus Neuromedical Announces Acquisition of StarFire Medical
Devices Mergers & Acquisitions Interventional Neurology
 HSMN NewsFeed - 12 Feb 2008
Nfocus Neuromedical Receives CE Mark for the CardioVasc(TM) Stent-Graft and Delivery System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Nov 2007
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2007
Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
Biopharmaceuticals Pain Mangement FDA
 HSMN NewsFeed - 21 Aug 2007
Neuromed Raises US$53.3 Million in Series E Financing to Accelerate Development of Pain Treatments
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Aug 2007
Neuromed Announces that Merck & Co., Inc. Discontinues Development of Pain Drug Candidate, Joint Research Program Continues
Biopharmaceuticals
 HSMN NewsFeed - 2 Aug 2007
Neuromed Appoints Mario Orlando as Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2007
Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 3 Apr 2007
Nfocus Neuromedical Inc. Raises Over $20 Million in Series B Financing
Devices Interventional Neurology Venture Capital
 HSMN NewsFeed - 3 Apr 2007
CardioVasc Acquires Acta Vascular Systems, Becomes Nfocus Neuromedical, Inc.
Devices Interventional Neurology Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 8 additional stories matching:
NeuroMed
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!